What is the single-use biopsy valves market forecast to be worth by 2036?
USD 228 million in 2026 to USD 445 million by 2036 at 6.9% CAGR.
- The Single-Use Biopsy Valves Market was valued at USD 210 million in 2025.
- The market is estimated at USD 228 million in 2026 and is projected to reach USD 445 million by 2036.
- The market is forecast to expand at 6.9% CAGR during the forecast period as infection prevention standards become stricter and endoscopy procedure volumes continue increasing.
What are the defining numbers behind single-use biopsy valve growth?
USD 217 million absolute opportunity by 2036 led by the United States and Germany.
- Demand Drivers in the Market
- Endoscopy procedure volumes continue increasing.
- Infection prevention standards are becoming stricter.
- Hospitals are adopting more sterile disposable accessories.
- Clinical guidelines continue supporting single-use products.
- Key Segments Analyzed
- By Valve Design: Slit Valves are expected to hold 36.0% share in 2026 because they provide dependable sealing during instrument exchange.
- By Procedure: Colonoscopy is projected to account for 39.0% share in 2026 because it represents the highest endoscopy procedure volume.
- By Packaging: Sterile Pouch is expected to hold 37.0% share in 2026 because it supports infection prevention and easy handling.
- By End User: Hospitals are projected to account for 56.0% share in 2026 because they perform the largest number of endoscopic procedures.
- By Geography: The United States is projected to record 7.3% CAGR through 2036.
- Analyst Opinion at Fact.MR
- Shambhu Nath Jha, Senior Analyst at Fact.MR, states, "Single-use biopsy valves are becoming an important part of infection prevention across endoscopy departments. Hospitals continue replacing reusable accessories with sterile alternatives that improve workflow efficiency and patient safety. Rising endoscopy procedure volumes will support long-term market growth."
- Strategic Implications
- Expand production of sterile biopsy valves.
- Improve compatibility across major endoscope platforms.
- Strengthen partnerships with hospitals and endoscopy centers.
- Invest in advanced infection prevention technologies.
Single-use biopsy valves are sterile accessories attached to flexible endoscopes. They allow instruments to pass through the working channel while helping maintain an effective seal and reducing contamination during procedures.
The United States is projected to record 7.3% CAGR through 2036 because hospitals continue increasing the use of disposable endoscopy accessories. Germany is expected to grow at 7.0% CAGR due to strong infection prevention practices. Japan is forecast to expand at 6.8% CAGR as healthcare providers adopt more single-use products. China is projected to register 6.6% CAGR through 2036 because endoscopy capacity continues expanding. South Korea is expected to grow at 6.4% CAGR due to rising investment in advanced diagnostic services.
How does the market break down by segment?
Slit Valves lead at 36.0%. Hospitals lead at 56.0%.
What makes slit valves the leading valve design?
Slit Valves account for 36.0% share in 2026.
Slit valves generate the highest demand because they create a secure seal during instrument exchange. They help maintain stable pressure while reducing fluid leakage throughout the procedure. Healthcare providers value this design because it supports smooth device movement. The simple construction also improves reliability during routine endoscopic procedures. The U.S. FDA classified a Class II recall for the Olympus MAJ-210 Single Use Biopsy Valve after Olympus identified a potential for rubber fragment detachment during use. Olympus initiated the field safety action on January 29, 2026, and advised healthcare providers to inspect the biopsy valves before use and follow the Instructions for Use (IFU) when inserting and withdrawing endotherapy accessories. [1]
Which procedure accounts for the highest product demand?
Colonoscopy holds 39.0% share in 2026.
Colonoscopy leads the procedure segment because screening programs continue expanding across many countries. Rising awareness of colorectal disease is also increasing diagnostic volumes. Disposable biopsy valves improve infection control during each procedure. They also reduce the need to reprocess reusable accessories.
Which packaging option is preferred by healthcare providers?
Sterile Pouch leads with 37.0% share in 2026.
Sterile pouch packaging remains the preferred option because each valve is supplied in a ready-to-use condition. This improves workflow while reducing preparation time. Healthcare facilities also benefit from better inventory control. Individual packaging supports compliance with infection prevention protocols. Demand remains steady across hospitals and outpatient centers. Diversatek Healthcare launched the BullDog® Disposable Bronchoscope Valves, a two-piece set including a suction valve and a biopsy valve. The product was developed based on customer feedback to improve procedural efficiency in pulmonary endoscopy. The biopsy valve is designed for easy installation and repeated device insertions during bronchoscopy procedures. [2]
Which end users create the strongest demand?
Hospitals hold 56.0% share in 2026.
Hospitals remain the largest customer group because they perform the highest number of endoscopic procedures. They also maintain strict standards for infection prevention. Many healthcare providers continue replacing reusable accessories with sterile disposable products. This supports safer procedures and more efficient operations.
Which factors are shaping market performance?
Higher procedure volumes support growth while cost remains a concern.
Demand continues increasing because gastrointestinal screening programs are expanding. More healthcare providers are adopting disposable accessories to improve infection prevention. Health Canada issued a Type II recall for Olympus MAJ-1443 (Suction Valve) and MAJ-1444 (Air/Water Valve), determining they are no longer compatible with OER-Pro and OER-Elite automated endoscope reprocessors. The notice states that use of these automated cleaners may fail to achieve high-level disinfection, potentially leaving valves contaminated. [3]
Clinical guidelines continue encouraging the use of sterile products. Better awareness of patient safety is also supporting wider adoption. Product pricing remains a challenge for some healthcare facilities. Higher disposable product use also increases medical waste.
Which areas offer the strongest growth potential?
- Outpatient Endoscopy: Outpatient procedure volumes continue increasing. Disposable valves support faster patient turnover.
- Pulmonary Diagnostics: Bronchoscopy demand continues growing. Sterile accessories improve procedural safety.
- Infection Prevention Programs: Hospitals continue strengthening infection control measures. Single-use products support these initiatives.
- OEM Supply Partnerships: Medical device manufacturers continue expanding accessory portfolios. New partnerships improve product availability.
- Developing Healthcare Markets: Healthcare infrastructure continues improving across emerging economies. Growing access to endoscopy services supports future demand.
Which countries are creating the strongest demand for single-use biopsy valves?
United States 7.3%, Germany 7.0%, Japan 6.8%, China 6.6%, South Korea 6.4%.
Based on regional analysis, the single-use biopsy valves market is segmented into North America, Western Europe, Asia Pacific, Latin America, and Middle East and Africa.
.webp "Top Country Growth Comparison Single Use Biopsy Valves Market Cagr (2026 2036)")
| Country |
CAGR (2026-2036) |
| United States |
7.3% |
| Germany |
7.0% |
| Japan |
6.8% |
| China |
6.6% |
| South Korea |
6.4% |
What supports growth in the United States?
7.3% CAGR, driven by higher screening volumes
The United States is projected to record 7.3% CAGR through 2036 because hospitals continue performing a large number of gastrointestinal procedures. Demand for sterile disposable accessories is also increasing across healthcare systems. Healthcare providers continue strengthening infection prevention practices. Rising adoption of single-use products further supports market expansion. The country leads demand for disposable biopsy valves.
Why is Germany an important market?
7.0% CAGR, supported by strict infection control
Germany is expected to expand at 7.0% CAGR through 2036 because healthcare providers continue improving endoscopy safety standards. Disposable biopsy valves are increasingly used to reduce contamination risk. Hospitals are also investing in procedure efficiency. Adoption of sterile accessories continues supporting market growth. Germany remains a leading European market for endoscopy products.
How is Japan expanding demand?
6.8% CAGR, backed by an aging population
Japan is projected to register 6.8% CAGR by 2036 because gastrointestinal screening continues increasing. The growing elderly population is supporting higher diagnostic procedure volumes. Healthcare providers continue adopting sterile disposable accessories. Patient safety remains an important purchasing factor. Japan continues supporting stable market expansion.
What is driving growth in China?
6.6% CAGR, supported by healthcare investment
China is forecast to grow at 6.6% CAGR through 2036 because hospital infrastructure continues expanding. More healthcare facilities are increasing endoscopy capacity across major cities. Demand for disposable biopsy valves is rising alongside stronger infection prevention standards. Diagnostic procedure volumes also continue increasing.
How is South Korea strengthening adoption?
6.4% CAGR, due to advanced healthcare services
South Korea is expected to record 6.4% CAGR through 2036 because hospitals continue investing in advanced endoscopy device. Demand for disposable accessories is increasing across diagnostic and therapeutic procedures. Healthcare providers continue focusing on procedure quality. Wider use of sterile products also supports market growth. South Korea continues strengthening its position in the regional market.
How are companies competing in the single-use biopsy valves market?
Olympus, CONMED, US Endoscopy, Micro-Tech Endoscopy lead the market
Competition is centered on sterile product quality and dependable clinical performance. Manufacturers are expanding disposable accessory portfolios to support infection prevention and improve workflow across endoscopy departments. Product development is also focused on stronger sealing performance, easier instrument exchange and compatibility with a wider range of endoscope systems.
Hospitals continue purchasing the largest volume of biopsy valves because procedure numbers remain high. Ambulatory surgery centers are also becoming an important customer group as outpatient endoscopy services expand. Gastroenterology clinics and pulmonology centers are increasing adoption as they seek reliable sterile accessories that simplify procedures and reduce contamination risk.
Olympus benefit from broad endoscopy product portfolios and established relationships with healthcare providers. CONMED continues expanding its gastrointestinal accessory business through product innovation. Steris strengthens its position with infection prevention solutions and disposable procedure products. Medtronic, Cook Medical, US Endoscopy and Micro-Tech continue investing in new accessory designs and wider hospital distribution.
Manufacturers that combine product reliability with dependable supply, responsive technical support and compliance with regulatory standards are expected to strengthen their competitive position through 2036.
Who are the leading manufacturers in the Single-Use Biopsy Valves Market?
Olympus, CONMED, US Endoscopy, Micro-Tech Endoscopy
- Olympus
- CONMED
- US Endoscopy (STERIS)
- Micro-Tech Endoscopy
- Diversatek Healthcare
Bibliography
- [1] U.S. Food and Drug Administration. (2026, March 3). Class 2 device recall: Olympus Single Use Biopsy Valve. FDA.
- [2] Olympus. (2026, January 29). Urgent field safety notice: Single Use Biopsy Valves. Olympus.
- [3] Diversatek Healthcare. (2026, February 19). Diversatek Healthcare expands BullDog® portfolio with new disposable bronchoscope valves. Diversatek Healthcare.
- [4] Health Canada. (2026, March 5). Olympus MAJ-1443 and MAJ-1444 valves. Health Canada.
This Report Addresses
- Strategic assessment of single-use biopsy valve technologies.
- Analysis of valve design and procedure trends.
- Evaluation of packaging formats and end-user demand.
- Regional outlook covering the United States, Germany, Japan, China and South Korea.
- Competitive assessment of major endoscopy accessory manufacturers.
- Analysis of infection prevention trends across endoscopy departments.
- Evaluation of outpatient procedure growth and hospital purchasing patterns.
- Primary interviews and supplier benchmarking supporting market estimates.
- Assessment of product innovation across disposable endoscopy accessories.
- Analysis of future opportunities in gastrointestinal and pulmonary endoscopy.
How is the market defined?
Sterile disposable biopsy valves used during endoscopic procedures.
The market covers single-use biopsy valves designed for gastrointestinal, pulmonary and ENT endoscopy. These products improve infection control and support efficient clinical procedures.
Which products are included?
Disposable biopsy valves and sterile valve kits.
The scope includes slit valves, cap valves, suction-compatible valves, leak-resistant valves and multi-access biopsy caps.
What falls outside the scope?
Reusable biopsy valves and complete endoscope systems.
The scope excludes reusable valve components, endoscope processors, and endoscopy visualization platforms.
What methodology supports this study?
100+ sources, 30+ company assessments, 25+ countries and industry interviews.
- Primary Research: Interviews with gastroenterologists, pulmonologists, hospital purchasing teams and medical device manufacturers.
- Desk Research: Analysis of endoscopy procedure volumes, infection prevention standards and healthcare investment.
- Market Sizing and Forecasting: Estimates based on procedure numbers, disposable accessory adoption and hospital purchasing trends.
- Data Validation and Update Cycle: Forecasts validated through supplier benchmarking and expert interviews.
